ABCLVSPRME• 7 Days (Normalized)
ABCL vs PRME (AbCellera Biologics Inc. vs Prime Medicine Inc.)
Showing Closing Date Range from Sep, 08 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ABCL Performance $11.41
-0.26%
AbCellera Biologics Inc.
Normalized Baseline0.00%
PRME Performance $3.14
-11.8%
Prime Medicine Inc.
Normalized Baseline0.00%
Alpha Spread Margin ABCL LEADS
+11.54%
ABCL outperforming by 11.54%
ABCLPRME
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ABCL PRME
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(6 dates)
| Date | ABCL Price | ABCL Gain (%) | PRME Price | PRME Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $11.41 | -0.26% | $3.14 | -11.80% | +11.54% |
| Sep 14, 2026 | $11.17 | -2.36% | $3.18 | -10.67% | +8.31% |
| Sep 11, 2026 | $10.89 | -4.81% | $3.13 | -12.08% | +7.27% |
| Sep 10, 2026 | $10.46 | -8.57% | $3.35 | -5.90% | -2.67% |
| Sep 09, 2026 | $11.05 | -3.41% | $3.47 | -2.53% | -0.88% |
| Sep 08, 2026 | $11.44 | +0.00% | $3.56 | +0.00% | +0.00% |